GAITHERSBURG, Md., Sept. 03, 2024 (GLOBE NEWSWIRE) — BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company […]
HOUSTON, Sept. 03, 2024 (GLOBE NEWSWIRE) — Today, Sysco Corporation (NYSE:SYY), the world’s largest food distributor, announced its winners from […]
GREENVILLE, S.C., Sept. 03, 2024 (GLOBE NEWSWIRE) — United Community Banks, Inc. (NYSE: UCB) (“United”) announced today the August 30th […]
Authorization expands use of bezisterim in a Phase 2, placebo-controlled, multicenter trial assessing bezisterim’s impact on neurological symptoms associated with […]
SALT LAKE CITY, Sept. 03, 2024 (GLOBE NEWSWIRE) — Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its […]
PRINCETON, N.J., Sept. 03, 2024 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming […]
MANNHEIM, Germany, Sept. 03, 2024 (GLOBE NEWSWIRE) — Affimed N.V. (Nasdaq: AFMD) (“Affimed” or the “Company”), a clinical-stage immuno-oncology company […]
The patented method reduces overhead data required in the forward error correction process based on specific characteristics of streamed media […]
MIAMI, Sept. 03, 2024 (GLOBE NEWSWIRE) — NCL Corporation Ltd. (“NCLC”), a subsidiary of Norwegian Cruise Line Holdings Ltd. (NYSE: […]
SINGAPORE and SHANGHAI, Sept. 03, 2024 (GLOBE NEWSWIRE) — H World Group Limited (NASDAQ: HTHT and HKEX: 1179) (“H World” […]
